Jeffrey Stein - 10 Dec 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: President & CEO, Director
Signature: /s/ Shane Ward, Attorney-in-Fact
Issuer symbol: CDTX
Transactions as of: 10 Dec 2025
Net transactions value: -$501,786
Form type: 4
Filing time: 12 Dec 2025, 19:43:05 UTC
Previous filing: 26 Jun 2025
Next filing: 07 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Stein Jeffrey	President & CEO, Director	6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO	/s/ Shane Ward, Attorney-in-Fact	12 Dec 2025	0001478831

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Tax liability	$501,786	-2,285	-3.9%	$219.60	56,199	10 Dec 2025	Direct	F1, F2
holding	CDTX	Common Stock						2,100	10 Dec 2025	By son
holding	CDTX	Common Stock						24,580	10 Dec 2025	By trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld for taxes on RSU vesting.
F2	Includes 600 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), representing 200 shares purchased on each of the following dates: November 20, 2024; May 20, 2025; and November 20, 2025.